Adam Errington

Adam Errington is an experienced Senior Medical Writer at Oxford PharmaGenesis, specializing in oncology, rare blood diseases, GI, artificial intelligence, digital medical devices, and diabetes since January 2020. Prior to this role, Adam served as a Senior Research Fellow at Cardiff University, where the Neurocircuits Lab Group was established and the electrophysiology and two-photon imaging theme was developed and led. Earlier experience includes positions as a Research Fellow and Postdoctoral Research Fellow. Adam holds a PhD in Neurobiology and Neurosciences from the University of Otago and a Bachelor of Science in Pharmacology from the University of Sunderland.